Scott Douglas

Scott Douglas has extensive work experience in the legal field. Scott is currently working as a Senior Director, Patent Counsel at Editas Medicine since May 2023. Prior to that, they worked for Finch Therapeutics Group as a Senior Counsel from March 2019 to May 2023, and as an Intellectual Property Counsel from May 2018 to March 2019. Before joining Finch Therapeutics Group, they served as an Associate at Wilson Sonsini Goodrich & Rosati from May 2017 to April 2018, and at Gowling WLG from September 2013 to April 2017.

Scott Douglas has pursued a PhD in Molecular Genetics from the University of Toronto. Additionally, they also pursued a JD in Law from the same university.